Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
Gabriela Pandini Silote, Michelle Carvalho Gatto, Amanda Eskelund, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1269-1269
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression
Sixin Li, Dong Yang, Chao Zhou, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 24
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression.
Luana B. Domingos, Heidi Kaastrup Müller, Nicole Rodrigues da Silva, et al.
Neuropharmacology (2024) Vol. 248, pp. 109870-109870
Closed Access | Times Cited: 6
An Updated Bio‐Behavioral Profile of the Flinders Sensitive Line Rat: Reviewing the Findings of the Past Decade
Stephan F. Steyn
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Cannabidiol alters psychophysiological, craving and anxiety responses in an alcohol cue reactivity task: A cross‐over randomized controlled trial
Tristan Hurzeler, Warren Logge, Joshua Watt, et al.
Alcohol Clinical and Experimental Research (2025) Vol. 49, Iss. 2, pp. 448-459
Open Access
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
Jaqueline Maisa Franzen, Isabel Werle, Felipe Vanz, et al.
Neuropharmacology (2022) Vol. 223, pp. 109316-109316
Closed Access | Times Cited: 19
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective
Sandra Ledesma‐Corvi, Elena Hernández‐Hernández, M. Julia García‐Fuster
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Luana B. Domingos, Nicole Rodrigues da Silva, Adriano José Maia Chaves Filho, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 13
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review
Giulia Menculini, Gianmarco Cinesi, Francesca Scopetta, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
Alice Hartmann dos Santos, Carla Vila-Verde, Francisco Silveira Guimarães, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 284-308
Open Access | Times Cited: 12
Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats
Elena Hernández‐Hernández, M. Julia García‐Fuster
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect
Matti Bock Guldager, Caroline Biojone, Nicole Rodrigues da Silva, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111029-111029
Open Access | Times Cited: 1
Sex and Estrous Cycle Are Not Mediators of S-Ketamine’s Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression
Shokouh Arjmand, Marie Vadstrup Pedersen, Nicole Rodrigues da Silva, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 350-358
Open Access | Times Cited: 4
Sex-Dependent Synergism of an Edible THC: CBD Formulation in Reducing Anxiety and Depressive-like Symptoms Following Chronic Stress
Enzo Pérez-Valenzuela, Roger Hudson, Taygun C. Uzuneser, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 12, pp. 2059-2078
Open Access | Times Cited: 4
Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice
Lígia Renata Rodrigues Tavares, Leonardo Abdelnur Petrilli, Daniela Baptista-de-Souza, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 3, pp. 699-713
Closed Access | Times Cited: 3
Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review
Cassidy Scott, Stefan Hall, Juan Zhou, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 227-227
Open Access | Times Cited: 2
β-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents
Ewa Galaj, Guo‐Hua Bi, Zheng‐Xiong Xi
Neuropharmacology (2024) Vol. 252, pp. 109947-109947
Closed Access
Therapeutic potential of cannabidiol in depression
Matti Bock Guldager, Adriano Maia Chaves Filho, Caroline Biojone, et al.
International review of neurobiology (2024), pp. 251-293
Closed Access
Efeito do canabidiol sobre as consequências da exposição ao isolamento social prolongado em camundongos fêmeas em diferentes idades: possível envolvimento da via do inflamassoma de NLRP3
Júlia Oliveira Bilibio
(2024)
Open Access
Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression
Nicole Rodrigues da Silva, Shokouh Arjmand, Luana Barreto Domingos, et al.
Pharmacological Research (2024), pp. 107545-107545
Open Access
Neurotoxic or Protective Cannabis Components: Delta-9-Tetrahydrocannabinol (Δ9THC) and Cannabidol (CBD)
Marilyn Silva
Journal of Exploratory Research in Pharmacology (2023) Vol. 8, Iss. 4, pp. 299-322
Open Access | Times Cited: 1
Protective effect of lavender essential oils on depression and multi-organ stress
Hafid Algristian, Tri Wahyuni Bintarti, Rani Nur Mukaromatim Baroroh, et al.
Bali Medical Journal (2022) Vol. 11, Iss. 3, pp. 1357-1363
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top